Che et al. reported that a decreased expression of claudin-3 significantly correlate with lymph node metastases, disease recurrence, and shorter overall survival in squamous cell lung carcinoma (9), whereas downregulation of claudin-4 in gastric cancer correlates with tumor aggressiveness and poor survival (10). This evidence concerns the gene CLDN3 and neoplasm.